Texts and a tiny sensor: new study aims to improve diabetes control without insulin

NCT ID NCT06296550

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing whether adding a continuous glucose monitor (CGM) to a text-message diabetes education program helps people with type 2 diabetes better manage their blood sugar. About 140 participants who do not use insulin will receive daily texts about diabetes care and a CGM to track glucose levels in real time. The main goal is to see if this combination lowers A1c levels over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitor (Dexcom G7) and text-based diabetes education
What this could lead to
If successful, this could show that combining real-time glucose monitoring with text support helps people with type 2 diabetes better manage their blood sugar without insulin.
What could go wrong
This is a small, early-stage study with only 140 participants and no blinding, so results may not apply to everyone. The intervention requires active participation and a compatible cellphone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Scripps Whittier Diabetes Institute

    RECRUITING

    San Diego, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.